大麻sativa生物活性化合物对结肠直肠癌发生的抗瘤作用
Rita Silva-Reis1,2, Artur M S Silva1, Paula A Oliveira2,3
1LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.
Biomolecules
|May 27, 2023
概括
包括大麻素和烯在内的大麻sativa化合物,通过影响瘤生长和细胞死亡,显示出治疗结直肠癌 (CRC) 的前景. 需要进一步的研究来证实它们在治疗CRC中的有效性和安全性.
科学领域:
- 药理学和瘤学 药理学和瘤学
- 自然产品化学 自然产品化学
背景情况:
- 大麻sativa是一种具有长期药用历史的植物.
- 生物活性化合物,如大麻素和C. sativa的烯,正因其潜在的治疗特性而引起人们的注意.
- 结肠直肠癌 (CRC) 是一个重大的健康问题,促使人们研究新的治疗策略.
研究的目的:
- 审查当前科学对大麻素和来自大麻sativa的类的理解,作为结直肠癌 (CRC) 治疗的潜在药物.
- 探索这些化合物可能对CRC产生抗瘤作用的机制.
- 突出CRC治疗中大麻素和烯之间的潜在协同相互作用,并确定未来研究的领域.
主要方法:
- 关于大麻sativa化合物及其对结直肠癌的影响现有科学研究的文献综述.
- 分析着重于作用的分子机制的研究,包括亡,增殖,血管新生和炎症.
- 在临床前模型或细胞研究中检查大麻素和烯之间协同作用的证据.
主要成果:
- 大麻素在CRC治疗中表现出潜力,通过影响细胞关键过程,如细胞亡,增殖,转移,炎症,血管新生,氧化应激和自.
- 特定的烯 (例如β-caryophyllene,limonene,myrcene) 也通过诱导细胞亡和抑制细胞增殖和血管生成,表现出对CRC的抗瘤潜力.
- 建议大麻素和烯之间的协同作用可以提高CRC治疗中的治疗结果.
结论:
- 来自Cannabis sativa的大麻素和类化合物代表了开发新型结直肠癌疗法的有希望的天然化合物.
- 这些化合物调节癌症的多个特征,提供了多重目标的方法.
- 进一步的严格研究是必不可少的,以充分了解它们的作用机制,优化它们的治疗应用,并确保它们在CRC中临床使用的安全性.
关键词:
大麻sativa是一种大麻.血管新生是因为血管新生.灭症 (apoptosis) 是一种死亡的过程.生物活性化合物 生物活性化合物大麻素是一种大麻素.结肠直肠癌是什么意思这是一种炎症炎症炎症炎症.转移 转移 转移 转移氧化应激是一种氧化应激.它们的扩散和扩散.它们是烯 (terpenes).更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.8K
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10.1K
相关概念视频
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
328
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
328
01:25Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
02:59Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
02:49Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K